Literature DB >> 9155653

Modulatory effect of interleukin-10 on the production of platelet-activating factor and superoxide anions by human leucocytes.

B Bussolati1, F Mariano, G Montrucchio, G Piccoli, G Camussi.   

Abstract

We observed that human monocytes (MO) and polymorphonuclear neutrophils (PMN) stimulated by lipopolysaccharide (LPS) produce platelet-activating factor (PAF) in a pattern characterized by an early and a delayed peak of synthesis. The early peak of PAF synthesis was due to a direct stimulation of these cells through mCD14 receptor as it was inhibited by anti-CD14 monoclonal antibody. The delayed and sustained peak of PAF synthesis was dependent on protein synthesis and cytokine production as shown by the inhibitory effect of cycloheximide on both MO and PMN, and of anti-tumour necrosis factor-alpha (anti-TNF-alpha) and of anti-interleukin-8 (anti-IL-8) neutralizing antibodies on MO and PMN respectively. IL-10 completely prevented this second, cytokine-dependent peak of PAF synthesis. In contrast, IL-10 markedly enhanced the first peak of PAF synthesis both in MO and PMN. Moreover, IL-10 was shown to modulate the production of superoxide anions (O2-) on both MO and PMN. As suggested by previous studies, IL-10 inhibited the delayed production of O2-. In the present study, we observed that IL-10 directly stimulated an early production of O2-. In addition, IL-10 enhanced the synthesis of O2- by MO and PMN challenged with LPS. The IL-10-induced O2- production was dependent, at least in part, from its effect on PAF synthesis, as it was inhibited by the PAF receptor antagonist WEB 2170. These results suggest that IL-10 may upregulate the early synthesis of PAF and O2- triggered by direct LPS stimulation, whereas it may downregulate the delayed production of these mediators.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9155653      PMCID: PMC1456595          DOI: 10.1111/j.1365-2567.1997.00440.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  33 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  Structural analysis of purified platelet-activating factor by lipases.

Authors:  J Benveniste; J P Le Couedic; J Polonsky; M Tence
Journal:  Nature       Date:  1977-09-08       Impact factor: 49.962

Review 3.  PAF molecular heterogeneity: pathobiological implications.

Authors:  L M McManus; D S Woodard; S I Deavers; R N Pinckard
Journal:  Lab Invest       Date:  1993-12       Impact factor: 5.662

Review 4.  Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.

Authors:  G Camussi
Journal:  Lab Invest       Date:  1994-04       Impact factor: 5.662

Review 5.  Septic shock--the unravelling of molecular mechanisms.

Authors:  G Camussi; G Montrucchio; L Dominioni; R Dionigi
Journal:  Nephrol Dial Transplant       Date:  1995-10       Impact factor: 5.992

6.  Platelet activating factor (PAF) involvement in endotoxin-induced hypotension in rats. Studies with PAF-receptor antagonist kadsurenone.

Authors:  T W Doebber; M S Wu; J C Robbins; B M Choy; M N Chang; T Y Shen
Journal:  Biochem Biophys Res Commun       Date:  1985-03-29       Impact factor: 3.575

7.  Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide.

Authors:  G Camussi; F Mariano; L Biancone; A De Martino; B Bussolati; G Montrucchio; P S Tobias
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

8.  Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14.

Authors:  J A Gegner; R J Ulevitch; P S Tobias
Journal:  J Biol Chem       Date:  1995-03-10       Impact factor: 5.157

9.  Interleukin (IL)-10 inhibits long-term IL-6 production but not preformed mediator release from rat peritoneal mast cells.

Authors:  J S Marshall; I Leal-Berumen; L Nielsen; M Glibetic; M Jordana
Journal:  J Clin Invest       Date:  1996-02-15       Impact factor: 14.808

10.  Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 beta in mediating the production of IL-8 triggered by lipopolysaccharide.

Authors:  M A Cassatella; L Meda; S Bonora; M Ceska; G Constantin
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  7 in total

1.  Effects of ceftriaxone on systemic and central expression of anti- and pro-inflammatory cytokines in alcohol-preferring (P) rats exposed to ethanol.

Authors:  P S S Rao; S Ahmed; Y Sari
Journal:  Alcohol Alcohol       Date:  2014-04-17       Impact factor: 2.826

2.  Effect of platelet-activating factor antagonists (BN-52021, WEB-2170, and BB-882) on bacterial translocation in acute pancreatitis.

Authors:  L J de Souza; S N Sampietre; R S Assis; C H Knowles; K R Leite; S Jancar; J E Monteiro Cunha; M C Machado
Journal:  J Gastrointest Surg       Date:  2001 Jul-Aug       Impact factor: 3.452

3.  IL-10 stimulates production of platelet-activating factor by monocytes of patients with active systemic lupus erythematosus (SLE).

Authors:  B Bussolati; C Rollino; F Mariano; F Quarello; G Camussi
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

4.  Interleukin-10 versus dexamethasone: effects on polymorphonuclear leukocyte functions of the newborn.

Authors:  Brett V Citarella; Veronika Miskolci; Ivana Vancurova; Dennis Davidson
Journal:  Pediatr Res       Date:  2009-04       Impact factor: 3.756

5.  Effects of PDE4 inhibitors on lipopolysaccharide-induced priming of superoxide anion production from human mononuclear cells.

Authors:  N Germain; M Corbel; C Belleguic; E Boichot; V Lagente
Journal:  Mediators Inflamm       Date:  2001-06       Impact factor: 4.711

Review 6.  Multiple Phenotypic Changes Define Neutrophil Priming.

Authors:  Irina Miralda; Silvia M Uriarte; Kenneth R McLeish
Journal:  Front Cell Infect Microbiol       Date:  2017-05-29       Impact factor: 5.293

7.  Contribution of increased ISG15, ISGylation and deregulated type I IFN signaling in Usp18 mutant mice during the course of bacterial infections.

Authors:  S M Dauphinee; E Richer; M M Eva; F McIntosh; M Paquet; D Dangoor; C Burkart; D-E Zhang; S Gruenheid; P Gros; M Behr; D Malo
Journal:  Genes Immun       Date:  2014-05-08       Impact factor: 2.676

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.